Allelotype Analysis of Childhood Acute Lymphoblastic Leukemia

Cancer Research

Volumn 55, Issue 22, 1995, Pages 5377-5382

  Takeuchi, Seisho ^a   Wada, Makio ^a   Hatta, Yoshihiro ^a   Lee, Elizabeth ^a   Miller, Carl W ^a   Koeffler, H Phillip ^a   Bartram, Claus R ^b   Seriu, Taku ^b   Reiter, Alfred ^c   Miyoshi, Isao ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELISM; ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME 12P; CHROMOSOME 9P; CHROMOSOME LOSS; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL;

ADOLESCENT; ALLELES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; FEMALE; HUMAN; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROTEIN P16; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028851928     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rowley, J. D. Recurring chromosome abnormalities in leukemia and lymphoma. Semin. Hematol., 27: 122–136, 1990.
2. Pui, C.-H., Crist, W. M., and Look, A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood, 76: 1449–1463, 1990.
3. Baer, M. R., and Bloomfield, C. D. Cytogenetics and oncogenes in leukemia. Curr. Opin. Oncol., 4: 24–32, 1992.
4. Johansson, B., Mertens, F., and Mitelman, F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes & Cancer, 8: 205–218, 1993.
5. Rowley, J. D. Rearrangements involving chromosome band llq23 in acute leukemia. Semin. Cancer Biol., 4: 377–385, 1993.
6. Machnicki, J. L., and Bloomfield, C. D. Clinical significance of the cytogenetics of acute leukemias. Oncology, 4: 23–30, 1990.
7. Raimondi, S. C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81: 2237–2251, 1993.
8. Wada, M., Bartram, C. R., Nakamura, H., Hachiya, M., Chen, D.-L., Borenstein, J., Miller, C. W., Ludwig, L., Hansen-Hagge, T. E., Ludwig, W.-D., Reiter, A., Mizogu-chi, H., and Koeffler, H. P. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood, 82: 3163–3169, 1993.
9. Chen, Y., Chen, P.-J., Yeh, S.-H., Tien, H.-F., Wang, C.-H., Tang, J.-L., and Hong, R.-L. Deletion of human retinoblastoma gene in primary leukemia. Blood, 76: 2060–2064, 1990.
10. Hebert, J., Cayuela, J. M., Berkeley, J., and Sigaux, F. Candidate tumor-suppressor genes MTS 1 (pl6 INK4A) and MTS 2 (pl5 INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038–4044, 1994.
11. Takeuchi, S., Bartram, C. R., Seriu, T., Miller, C. W., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W.-D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I., and Koeffler, H. P. Analysis of a family of cyclin-dependent kinase inhibitors: pl5/MJSV INK4B, pl6/MTSl/INK4A and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86: 755–760, 1995.
12. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res., 54: 531–538, 1994.
13. Mitra, A.-B., Murty, V. V. V. S., Li, R. G., Pratap, M., Luthra, U. K., and Chaganti, R. S. K. Allelotype analysis of cervical carcinoma. Cancer Res., 54: 4481–4487,1994.
14. Fujino, T., Risinger, J. I., Collins, N. K., Liu, F.-S., Nishii, H., Takahashi, H., Westphal, E.-M., Barrett, J. C., Sasaki, H., Kohler, M. F., Berchuck, A., and Boyd, J. Allelotype of endometrial carcinoma. Cancer Res., 54: 4294–4298, 1994.
15. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152–1155, 1994.
16. Aoki, T., Mori, T., Xiqun, D., Nisihira, T., Matsubara, T., and Nakamura, Y. Allelotype study of esophageal carcinoma. Genes Chromosomes & Cancer, 10: 177–182, 1994.
17. Tsuchiya, E., Nakamura, Y., Weng, S.-Y., Nakagawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478–2481, 1992.
18. Seymour, A. B., Hruban, R. H., Redston, M., Caldas, C., Powell, S. M., Kinzler, K. W., Yeo, C. J., and Kern, S. E. Allelotype of pancreatic adenocarcinoma. Cancer Res., 54: 2761–2764, 1994.
19. Vogelstein, B., Fearon, E. R., Kern, S., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207–211, 1989.
20. Yamaguchi, T., Toguchida, J., Yamamuro, T., Kotoura, Y., Takada, N., Kawaguchi, N., Kaneko, Y., Nakamura, Y., Sasaki, M., and Ishizaki, K. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res., 52: 2419–2423, 1992.
21. Litt, M., and Luty, J. A. A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am. J. Hum. Genet., 44: 397–401, 1989.
22. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., and Lathrop, M. A second-generation linkage map of the human genome. Nature (Lond.), 359: 794–801, 1992.
23. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W.-C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A. J., and Testa, J. R. pl6 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54: 5547–5551, 1994.
24. Chilcote, R. R., Brown, E., and Rowley, J. D. Lymphoblastic leukemia with lym-phomatous features associated with abnormalities of the short arm of chromosome 9. N. Engl. J. Med., 313: 286–291, 1985.
25. Carroll, A. J., Castleberry, R. P., and Crist, W. M. Lack of association between abnormalities of chromosome 9 short arm and either “lymphomatous” features or T cell phenotype in childhood acute lymphocytic leukemia. Blood, 69: 735–738, 1987.
26. Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., Lahti, J., Kidd, V. J., Housman, D. E., and Dracopoli, N. C. Homozygous deletions of human chromosome 9p21 in melanoma. Proc. Natl. Acad. Sci. USA, 89: 10557–10561, 1992.
27. Ichimura, K., Schmidt, E. E., Yamaguchi, N., James, C. J., and Collins, V. P. A common region of homozygous deletion in malignant human gliomas lies between the IFN α/ω gene cluster and the D9S171 locus. Cancer Res., 54: 3127–3130, 1994.
28. Olopade, O. I., Jenkins, R. B., Ransom, D. T., Malik, K., Pomykala, H., Nobori, T., Cowan, J. M., Rowley, J. D., and Diaz, M. O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res., 52: 2523–2529, 1992.
29. Merlo, A., Gabrielson, E., Askin, F., and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54: 640–642, 1994.
30. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B., and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54: 2322–2326, 1994.
31. Olopade, O. I., Buchhagen, D. L., Malik, K., Sherman, J., Nobori, T., Bader, S., Nau, M. M., Gazdar, A. F., Minna, J. D., and Diaz, M. O. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancer. Cancer Res., 53: 2410–2415, 1993.
32. van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res., 54: 1156–1158, 1994.
33. Huang, D. P., Lo, K.-W., van Hasselt, C. A., Woo, J. K. S., Choi, P. H. K., Leung, S.-F., Cheung, S.-T., Cairns, P., Sidransky, D., and Lee, J. C. K. A region of homozygous deletion on chromosome 9p21–22 in primary nasopharyngeal carcinoma. Cancer Res., 54: 4003–4006, 1994.
34. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletion of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422–1424, 1994.
35. Diaz, M. O., Ziemin, S., Le Beau, M. M., Pitha, P., Smith, S. D., Chilcote, R. R., and Rowley, J. D. Homozygous deletion of the α- and β,- interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA, 85: 5259–5263, 1988.
36. Diaz, M. O., Rubin, C. M., Harden, A., Ziemin, S., Larson, R. A., Le Beau, M. M., and Rowley, J. D. Deletion of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med., 322: 77–82, 1990.
37. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Lin, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436–440, 1994.
38. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, A. D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753–756, 1994.
39. Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massagué, J. Cloning of p27Klpl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59–66, 1994.
40. Sato, Y., Suto, Y., Pietenpol, J., Golub, T. R., Gilliland, D. G., Davis, E. M., Le Beau, M. M., Roberts, J. M., Vogelstein, B., Rowley, J. D., and Bohlander, S. K. TEL and KIP1 define the smallest region of deletions in hematopoetic malignancies. Blood, 86: 1525–1533, 1995.
41. Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulos, N., Lin, B., Friedman, C., Trask, B. J., Roberts, J. M., Kinzler, K. W., Rowley, J. D., and Vogelstein, B. Assignment of the human p27k,pl gene to 12pl3 and its analysis in leukemia. Cancer Res., 55: 1206–1210, 1995.
42. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartram, C. R., and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor p27/kipl in human malignancies. Cancer Res., 55: 2266–2269, 1995.
43. Raimondi, S. C., Williams, D. L., Callihan, T., Peiper, S., Rivera, G. K., and Murphy, S. B. Nonrandom involvement of the 12pl2 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood, 68: 69–75, 1986.
44. Pui, C.-H., Carroll, A. J., Raimondi, S. C., Land, V. J., Crist, W. M., Shuster, J. J., Williams, D. L., Pullen, D. J., Borowitz, M. J. Behm, F. G., and Look, A. T. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid < 45 line. Blood, 75: 1170–1177, 1990.